Globe Life stock
Price history
+21.11% over the period1 year: from $131.43 (November 17, 2025) to $159.17 (November 17, 2026), +21.11%.
Show chart data
Closing prices adjusted for splits: the last close of each month.
| Date | Close |
|---|---|
| November 17, 2026 | $159.17 |
| October 30, 2026 | $159.08 |
| September 30, 2026 | $165.65 |
| August 31, 2026 | $172.67 |
| July 31, 2026 | $182.25 |
| June 30, 2026 | $178.68 |
| May 29, 2026 | $153.24 |
| April 30, 2026 | $154.30 |
| March 31, 2026 | $139.17 |
| February 27, 2026 | $145.26 |
| January 30, 2026 | $140.22 |
| December 31, 2025 | $139.86 |
| November 28, 2025 | $134.73 |
| November 17, 2025 | $131.43 |
At a glance
The company
Provides life and supplemental health insurance products to middle-income families in the United States through direct and agent channels
Latest results
Quarter to September 30, 2026 · EPS $4.84 (estimate $4.91)
Next event
Dividend
TickerLandia's take on Globe Life
- Priced as usual relative to earnings: P/E on the latest fiscal year 11 vs a median of 12 over its last 10 fiscal years.
- Cheaper than similar companies: trailing 12-month P/E 11 vs 17 (−38%) in a group of 10.
- Strong point: Profitability (74/100 in its group). Weak point: Growth (35/100).
Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks
Where the price stands
−17.49% from the 52-week high
Analysts · 11 analysts
Average target$185.18+17.17% vs. price
Buy 7 · Hold 4 · Sell 0 · Buy
TickerLandia Fingerprint: Globe Life
Compared with similar companies: low risk, high profitability, and low growth.
Financials and price compared with 32 companies in the insurance - life industry, worldwide. Momentum and risk compared with 883 North American stocks.
Priceaverage52
How much it costs relative to what it produces.
Metric Value Position in group P/E (trailing 12 months) 10.8 32 Price/book 1.83 60 Price/sales 1.91 73 Forward P/E 10.1 44 Profitabilityhigh74
How much it earns on revenue and capital.
Metric Value Position in group ROA 3.3% 95 Operating margin 25.8% 67 ROE 19.3% 67 Net margin 18.9% 67 Earnings stabilityaverage59
How steady its margins were over the last five annual reports.
Metric Value Position in group Loss-making yearscounts in reverse: lower means more earnings stability 0 of 5 annual reports 59 Margin variabilitycounts in reverse: lower means more earnings stability 2.4% 58 Growthlow35
How fast revenue and earnings are growing.
Metric Value Position in group Revenue growth (year over year) +5.48% 40 Earnings growth (year over year) −2.33% 40 Average revenue growth (3 years) +4.67% 24 Financial strengthdoes not apply to banks and insurers
How well it would weather a hard period: debt, liquidity, interest.
Dividendlow36
How much it returns to shareholders, and for how long.
Metric Value Position in group Payout ratio 8.4% 2 Consecutive dividend years at least 37 years 97 Dividend yield 0.8% 8 Market momentumaverage44
How the stock has moved compared with the market.
Metric Value Position in group Relative strength (3 months) −9.33% 27 Relative strength (6 months) +0.72% 45 1-year return +20.92% 62 Distance from 200-day average −0.94% 41 Risklow24
How much the price swings.
Metric Value Position in group Volatility (60 days) 23.9% 21 Beta (1 year) 0.37 34 Maximum drawdown (12 months) 16.8% 15
Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 17, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated
Valuation
Globe Life is priced as in the past and cheaper than similar companies
On the latest fiscal year's earnings (2025), Globe Life's P/E today is 11.3, in line with the median of its last 10 fiscal years (12.2; between 7.42 and 16.4 from 2016 to 2025). Globe Life's P/E (trailing 12 months): 10.8, −38% against the median of a group of 10 similar companies (17.5).
Compared with 10 similar companies
| Metric | Globe Life | Position in the group | Band |
|---|---|---|---|
| P/E (trailing 12 months) | 10.8 | Low | |
| Forward P/E | 10.0 | Low | |
| ROE | 19.3% | High | |
| Price/book | 1.83 | Middle |
P/E at fiscal year end; today on the latest fiscal year's earnings. Grey band: the middle half of the group; tick: the median; dot: Globe Life. All multiples and dividends
TickerLandia analysisHow it is calculated
The financials
The business in numbers
Revenue
$1.6B
Latest quarter · Q3 2026
Net income
$361.11M
Latest quarter · Q3 2026
Quarterly net margin
22.6%
Latest quarter · Q3 2026
Numbers and valuation
Full valuation- Market cap
- $12.21B
- P/E
- 10.8
- EPS
- $14.92
- Volume
- 389.67K
- Daily trading
- €95.1M
- Dividend yield
- 0.80%
How Globe Life is changing
All resultsRevenue grew 4.8% a year on average over the last 5 years
Shares outstanding down 23.0% in 5 years
Revenue has grown for 9 fiscal years in a row
Returns
Globe Life returns with dividends
$1,000 invested in Globe Life 5 years ago, on November 17, 2021, would be worth $1,762 today with dividends reinvested: +76.16% in total, +11.99% per year. On price alone it would be $1,690 (+68.97%).
| Period | Globe Life | S&P 500 | $1,000 becomes |
|---|---|---|---|
| 1 month | −5.17% | −3.17% | $948 |
| 6 months | +1.93% | +0.11% | $1,019 |
| Year to date | +13.81% | +8.34% | $1,138 |
| 1 year | +22.09% | +11.15% | $1,221 |
| 3 years | +38.06% | +64.30% | $1,381 |
| 5 years | +76.16% | +58.18% | $1,762 |
| 10 years | +146.28% | +239.10% | $2,463 |
Over the last 6 months it has done better than 52% of the stocks in the Finance sector.
From 1 year up with dividends reinvested, before taxes; under a year price only. S&P 500: price only. Calculate your investment
The chart in detail
Globe Life: technical analysis
Globe Life shows no clear trend: the price and its 50- and 200-session averages are not aligned. The price is 15.0% below its highest close since January 2, 1990 ($186.02, August 6, 2026).
- Trend
- No clear trend
- RSI (14 sessions)
- 42
- Between 30 and 70
- vs 200-session average
- −1.82%
Support and resistance
Price areas where Globe Life has stopped several times in the last year. They describe the chart; they are not forecasts.
- Resistance$176.02+11.38%3 touches, last on September 16, 2026
- Resistance$170.43+7.84%2 touches, last on October 21, 2026
- Resistance$167.86+6.21%3 touches, last on October 6, 2026
- Last price$158.04
- Support$157.14−0.57%3 touches, last on November 6, 2026
- Support$153.96−2.58%3 touches, last on October 23, 2026
- Support$147.70−6.54%5 touches, last on June 3, 2026
Volatility and risk
Over the last year it has moved little with the S&P 500.
- Beta (1 year) vs S&P 500
- 0.37
- Volatility (60 sessions, annualised)
- 23.8%
- Largest fall in the last year
- −16.79%
Close of November 17, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it
Globe Life: seasonality
Average monthly price change over 37 years
Over the last 37 years, the strongest month for Globe Life has been July: +2.47% on average, positive in 24 years out of 37. The weakest has been September: −0.24% on average, positive in 21 years out of 37. November, the current month, has been positive in 29 years out of 36 (+2.39% on average).
Show chart data
| Month | Average | Median | Positive years |
|---|---|---|---|
| January | −0.01% | +0.59% | 22 of 36 |
| February | +0.04% | +0.86% | 21 of 37 |
| March | +0.84% | −0.25% | 18 of 37 |
| April | +0.94% | +1.27% | 21 of 37 |
| May | +1.72% | −0.52% | 17 of 37 |
| June | +0.07% | +0.24% | 19 of 37 |
| July | +2.47% | +2.08% | 24 of 37 |
| August | −0.21% | −0.17% | 17 of 37 |
| September | −0.24% | +0.33% | 21 of 37 |
| October | +1.75% | +1.58% | 22 of 37 |
| November | +2.39% | +2.47% | 29 of 36 |
| December | +1.94% | +2.05% | 26 of 36 |
Price change only, dividends excluded. Past seasonality does not predict future moves.
The company
Globe Life and its competitors
Whole and term life policies, Medicare supplement plans and final expense coverage are among the products Globe Life offers, alongside accidental death, mortgage protection and hospital insurance. Its customers are mainly households across the United States with lower middle or middle incomes, reached through direct-to-consumer channels, exclusive agents, general agencies and brokers. Operations are grouped into three segments: life insurance, supplemental health insurance and investments. Life insurance for children is also part of the offer.
- Headquarters
- McKinney, United States
- Employees
- 3,695
- Founded
- 1900
| Company | Market cap | ROE | P/E (trailing 12 months) | 6 months |
|---|---|---|---|---|
| Globe LifeGL | $12.21B | 19.3% | 10.8 | +1.93% |
| Prudential FinancialPRU | $40.35B | 12.0% | 10.6 | +20.02% |
| Power Corporation of CanadaPOW | $41.01B | 11.2% | 20.5 | +19.31% |
| Great-West LifecoGWO | $58.72B | 14.4% | 19.3 | +21.58% |
| AflacAFL | $63.12B | 12.2% | 18.6 | +9.31% |
| MetLifeMET | $64.51B | 19.9% | 13.3 | +27.22% |
Same industry or related industries, similar size. Compare Globe Life with its competitors · Full profile
